In fact, Inan et al. [10] studied that butyrate have a prominent anti-inflammatory effect in colitis, suppressing the NF-κB activity, while Liu et al. [11] established that acetate could prevent LPS-induced NF-κB protein 65 translocation to the nucleus. Here, NFKB1 is linked to colitis.